25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

BioMark Diagnostics Inc
Buy, Hold or Sell?

Let's analyze BioMark Diagnostics Inc together

I guess you are interested in BioMark Diagnostics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of BioMark Diagnostics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about BioMark Diagnostics Inc

I send you an email if I find something interesting about BioMark Diagnostics Inc.

Quick analysis of BioMark Diagnostics Inc (30 sec.)










What can you expect buying and holding a share of BioMark Diagnostics Inc? (30 sec.)

How much money do you get?

How much money do you get?
C$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
C$-0.01
Expected worth in 1 year
C$-0.04
How sure are you?
44.4%

+ What do you gain per year?

Total Gains per Share
C$-0.02
Return On Investment
-10.3%

For what price can you sell your share?

Current Price per Share
C$0.22
Expected price per share
C$0.2 - C$0.285
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

1. Valuation of BioMark Diagnostics Inc (5 min.)




Live pricePrice per Share (EOD)

C$0.22

Intrinsic Value Per Share

C$-0.13 - C$-0.08

Total Value Per Share

C$-0.15 - C$-0.09

2. Growth of BioMark Diagnostics Inc (5 min.)




Is BioMark Diagnostics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$832.8k-$460.5k-$372.3k-44.7%

How much money is BioMark Diagnostics Inc making?

Current yearPrevious yearGrowGrow %
Making money-$1.3m-$1m-$281.3k-21.1%
Net Profit Margin-1,200.2%-3,309.4%--

How much money comes from the company's main activities?

3. Financial Health of BioMark Diagnostics Inc (5 min.)




4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  

3rd party ad coffee SUPPORTERis ad-free.

What can you expect buying and holding a share of BioMark Diagnostics Inc? (5 min.)

Welcome investor! BioMark Diagnostics Inc's management wants to use your money to grow the business. In return you get a share of BioMark Diagnostics Inc.

What can you expect buying and holding a share of BioMark Diagnostics Inc?

First you should know what it really means to hold a share of BioMark Diagnostics Inc. And how you can make/lose money.

Speculation

The Price per Share of BioMark Diagnostics Inc is C$0.22. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of BioMark Diagnostics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in BioMark Diagnostics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is C$-0.01. Based on the TTM, the Book Value Change Per Share is C$-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is C$-0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is C$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of BioMark Diagnostics Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 C$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per Share
Usd Eps-0.01-6.7%-0.01-6.7%-0.01-5.3%-0.01-4.5%-0.01-4.8%
Usd Book Value Change Per Share0.00-1.9%0.00-1.9%0.00-2.0%0.00-0.2%0.00-0.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.00-1.9%0.00-1.9%0.00-2.0%0.00-0.2%0.00-0.5%
Usd Price Per Share0.15-0.15-0.17-0.16-0.15-
Price to Earnings Ratio-10.36--10.36--14.38--16.78--14.07-
Price-to-Total Gains Ratio-37.14--37.14--37.56-6.75-31.04-
Price to Book Ratio-16.60--16.60--32.88--114.84--41.17-
Price-to-Total Gains Ratio-37.14--37.14--37.56-6.75-31.04-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.15939
Number of shares6273
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (6273 shares)-25.70-2.49
Gains per Year (6273 shares)-102.79-9.97
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-103-1130-10-20
20-206-2160-20-30
30-308-3190-30-40
40-411-4220-40-50
50-514-5250-50-60
60-617-6280-60-70
70-720-7310-70-80
80-822-8340-80-90
90-925-9370-90-100
100-1028-10400-100-110

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.09.00.00.0%0.09.00.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%4.05.00.044.4%4.05.00.044.4%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.09.00.0%0.00.09.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%4.05.00.044.4%4.05.00.044.4%
3rd party ad coffee SUPPORTERis ad-free.

Fundamentals of BioMark Diagnostics Inc

About BioMark Diagnostics Inc

Biomark Diagnostics Inc., an oncology focused company, develops cancer diagnostic solutions to detect, monitor, and assess early treatment. It holds an agreement with National Research Council of Canada Industrial Research Assistance Program to support research and development of liquid biopsy assay for the early detection and screening of lung cancer; and strategic partnership with Rubix LS to develop diagnostic tools to enhance lung cancer screening and improve breast cancer screening program for women with dense breasts. The company was incorporated in 2014 and is headquartered in Richmond, Canada. Biomark Diagnostics Inc. operates as a subsidiary of Biomark Technologies Inc.

Fundamental data was last updated by Penke on 2024-07-10 19:14:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

1.1. Profitability of BioMark Diagnostics Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit BioMark Diagnostics Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare¬†BioMark Diagnostics Inc to the¬†Diagnostics & Research industry mean.
  • A Net Profit Margin of -1,200.2%¬†means that¬†$-12.00 for each $1¬†in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of BioMark Diagnostics Inc:

  • The MRQ is -1,200.2%. The company is making a huge loss. -2
  • The TTM is -1,200.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-1,200.2%TTM-1,200.2%0.0%
TTM-1,200.2%YOY-3,309.4%+2,109.1%
TTM-1,200.2%5Y-994.2%-206.0%
5Y-994.2%10Y-7,560.0%+6,565.7%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,200.2%-9.4%-1,190.8%
TTM-1,200.2%-11.3%-1,188.9%
YOY-3,309.4%-3.6%-3,305.8%
5Y-994.2%-2.2%-992.0%
10Y-7,560.0%-0.5%-7,559.5%
1.1.2. Return on Assets

Shows how efficient BioMark Diagnostics Inc is using its assets to generate profit.

  • Above 5% is considered healthy¬†but always compare¬†BioMark Diagnostics Inc to the¬†Diagnostics & Research industry mean.
  • -251.6% Return on Assets means that¬†BioMark Diagnostics Inc generated¬†$-2.52 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of BioMark Diagnostics Inc:

  • The MRQ is -251.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -251.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-251.6%TTM-251.6%0.0%
TTM-251.6%YOY-98.8%-152.8%
TTM-251.6%5Y-446.2%+194.6%
5Y-446.2%10Y-1,205.2%+759.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-251.6%-2.3%-249.3%
TTM-251.6%-2.0%-249.6%
YOY-98.8%-0.6%-98.2%
5Y-446.2%-0.3%-445.9%
10Y-1,205.2%-0.3%-1,204.9%
1.1.3. Return on Equity

Shows how efficient BioMark Diagnostics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare¬†BioMark Diagnostics Inc to the¬†Diagnostics & Research industry mean.
  • 0.0% Return on Equity means BioMark Diagnostics Inc generated $0.00¬†for each¬†$1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of BioMark Diagnostics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-215.9%+215.9%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ--0.7%+0.7%
TTM--1.9%+1.9%
YOY--0.3%+0.3%
5Y--0.9%+0.9%
10Y-215.9%-1.5%-214.4%
3rd party ad coffee SUPPORTERis ad-free.

1.2. Operating Efficiency of BioMark Diagnostics Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient BioMark Diagnostics Inc is operating .

  • Measures how much profit BioMark Diagnostics Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare¬†BioMark Diagnostics Inc to the¬†Diagnostics & Research industry mean.
  • An Operating Margin of 0.0%¬†means the company generated $0.00 ¬†for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of BioMark Diagnostics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-2,922.5%+2,922.5%
TTM-5Y-674.5%+674.5%
5Y-674.5%10Y-5,712.1%+5,037.6%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ--16.4%+16.4%
TTM--9.5%+9.5%
YOY-2,922.5%1.6%-2,924.1%
5Y-674.5%2.0%-676.5%
10Y-5,712.1%3.5%-5,715.6%
1.2.2. Operating Ratio

Measures how efficient BioMark Diagnostics Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to¬†Diagnostics & Research industry mean).
  • An Operation Ratio of 12.28 means that the operating costs are $12.28 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of BioMark Diagnostics Inc:

  • The MRQ is 12.285. The company is inefficient in keeping operating costs low. -1
  • The TTM is 12.285. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ12.285TTM12.2850.000
TTM12.285YOY32.937-20.653
TTM12.2855Y10.163+2.122
5Y10.16310Y59.020-48.857
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ12.2851.369+10.916
TTM12.2851.327+10.958
YOY32.9371.263+31.674
5Y10.1631.245+8.918
10Y59.0201.155+57.865
3rd party ad coffee SUPPORTERis ad-free.

1.3. Liquidity of BioMark Diagnostics Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if BioMark Diagnostics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to¬†Diagnostics & Research industry mean).
  • A Current Ratio of 0.08¬†means the company has $0.08 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of BioMark Diagnostics Inc:

  • The MRQ is 0.076. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.076. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.076TTM0.0760.000
TTM0.076YOY0.332-0.257
TTM0.0765Y0.404-0.328
5Y0.40410Y0.551-0.147
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0762.031-1.955
TTM0.0762.238-2.162
YOY0.3322.568-2.236
5Y0.4042.830-2.426
10Y0.5512.925-2.374
1.3.2. Quick Ratio

Measures if BioMark Diagnostics Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but¬†always compare¬†BioMark Diagnostics Inc to the¬†Diagnostics & Research industry mean.
  • A Quick Ratio of 0.06¬†means the company can pay off $0.06 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of BioMark Diagnostics Inc:

  • The MRQ is 0.064. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.064. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.064TTM0.0640.000
TTM0.064YOY0.310-0.246
TTM0.0645Y0.393-0.329
5Y0.39310Y0.539-0.147
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0641.219-1.155
TTM0.0641.247-1.183
YOY0.3101.617-1.307
5Y0.3931.929-1.536
10Y0.5392.234-1.695
3rd party ad coffee SUPPORTERis ad-free.

1.4. Solvency of BioMark Diagnostics Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of BioMark Diagnostics Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare¬†BioMark Diagnostics Inc to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 2.57¬†means that BioMark Diagnostics Inc assets are¬†financed with 257.0% credit (debt) and the remaining percentage (100% - 257.0%)¬†is financed by its owners/shareholders.¬†

Let's take a look of the Debt to Asset Ratio trends of BioMark Diagnostics Inc:

  • The MRQ is 2.570. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 2.570. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ2.570TTM2.5700.000
TTM2.570YOY1.432+1.138
TTM2.5705Y8.594-6.024
5Y8.59410Y11.895-3.301
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.5700.429+2.141
TTM2.5700.390+2.180
YOY1.4320.367+1.065
5Y8.5940.424+8.170
10Y11.8950.442+11.453
1.4.2. Debt to Equity Ratio

Measures if BioMark Diagnostics Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but¬†always compare¬†BioMark Diagnostics Inc to the¬†Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of BioMark Diagnostics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y0.062-0.062
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.613-0.613
TTM-0.570-0.570
YOY-0.478-0.478
5Y-0.639-0.639
10Y0.0620.706-0.644
3rd party ad coffee SUPPORTERis ad-free.

2. Market Valuation of BioMark Diagnostics Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings BioMark Diagnostics Inc generates.

  • Above 15 is considered overpriced but¬†always compare¬†BioMark Diagnostics Inc to the¬†Diagnostics & Research industry mean.
  • A PE ratio of -10.36 means the investor is paying $-10.36¬†for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of BioMark Diagnostics Inc:

  • The EOD is -10.854. Based on the earnings, the company is expensive. -2
  • The MRQ is -10.360. Based on the earnings, the company is expensive. -2
  • The TTM is -10.360. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-10.854MRQ-10.360-0.493
MRQ-10.360TTM-10.3600.000
TTM-10.360YOY-14.378+4.017
TTM-10.3605Y-16.783+6.422
5Y-16.78310Y-14.068-2.714
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-10.854-0.343-10.511
MRQ-10.360-0.857-9.503
TTM-10.360-0.498-9.862
YOY-14.378-0.085-14.293
5Y-16.7832.211-18.994
10Y-14.0683.498-17.566
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of BioMark Diagnostics Inc:

  • The EOD is -21.740. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -20.752. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -20.752. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-21.740MRQ-20.752-0.988
MRQ-20.752TTM-20.7520.000
TTM-20.752YOY-16.549-4.203
TTM-20.7525Y-35.669+14.917
5Y-35.66910Y-34.481-1.188
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-21.740-0.981-20.759
MRQ-20.752-1.362-19.390
TTM-20.752-1.242-19.510
YOY-16.549-2.859-13.690
5Y-35.669-0.591-35.078
10Y-34.481-2.357-32.124
3rd party ad coffee SUPPORTERis ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of BioMark Diagnostics Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy¬†(always compare to Diagnostics & Research industry mean).
  • A PB ratio of -16.60 means the investor is paying $-16.60¬†for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of BioMark Diagnostics Inc:

  • The EOD is -17.393. Based on the equity, the company is expensive. -2
  • The MRQ is -16.603. Based on the equity, the company is expensive. -2
  • The TTM is -16.603. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-17.393MRQ-16.603-0.791
MRQ-16.603TTM-16.6030.000
TTM-16.603YOY-32.884+16.281
TTM-16.6035Y-114.841+98.238
5Y-114.84110Y-41.169-73.672
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-17.3931.928-19.321
MRQ-16.6032.157-18.760
TTM-16.6032.159-18.762
YOY-32.8842.787-35.671
5Y-114.8413.884-118.725
10Y-41.1694.469-45.638
2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

3. Summary

3.1. Key Performance Indicators

The key performance indicators of BioMark Diagnostics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.006-0.0060%-0.006+8%-0.001-90%-0.001-75%
Book Value Per Share---0.013-0.0130%-0.007-45%-0.008-39%-0.007-43%
Current Ratio--0.0760.0760%0.332-77%0.404-81%0.551-86%
Debt To Asset Ratio--2.5702.5700%1.432+79%8.594-70%11.895-78%
Debt To Equity Ratio----0%-0%-0%0.062-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.020-0.0200%-0.016-21%-0.014-33%-0.015-28%
Free Cash Flow Per Share---0.010-0.0100%-0.014+37%-0.007-27%-0.008-24%
Free Cash Flow To Equity Per Share---0.003-0.0030%-0.005+59%0.001-498%0.000-947%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---0.078--------
Intrinsic Value_10Y_min---0.134--------
Intrinsic Value_1Y_max---0.008--------
Intrinsic Value_1Y_min---0.011--------
Intrinsic Value_3Y_max---0.023--------
Intrinsic Value_3Y_min---0.035--------
Intrinsic Value_5Y_max---0.038--------
Intrinsic Value_5Y_min---0.061--------
Market Cap19994964.000+5%19086102.00019086102.0000%20903826.000-9%20085850.200-5%18278224.667+4%
Net Profit Margin---12.002-12.0020%-33.094+176%-9.942-17%-75.600+530%
Operating Margin----0%-29.2250%-6.7450%-57.1210%
Operating Ratio--12.28512.2850%32.937-63%10.163+21%59.020-79%
Pb Ratio-17.393-5%-16.603-16.6030%-32.884+98%-114.841+592%-41.169+148%
Pe Ratio-10.854-5%-10.360-10.3600%-14.378+39%-16.783+62%-14.068+36%
Price Per Share0.220+5%0.2100.2100%0.230-9%0.221-5%0.201+4%
Price To Free Cash Flow Ratio-21.740-5%-20.752-20.7520%-16.549-20%-35.669+72%-34.481+66%
Price To Total Gains Ratio-38.909-5%-37.141-37.1410%-37.556+1%6.754-650%31.042-220%
Quick Ratio--0.0640.0640%0.310-79%0.393-84%0.539-88%
Return On Assets---2.516-2.5160%-0.988-61%-4.462+77%-12.052+379%
Return On Equity----0%-0%-0%-2.1590%
Total Gains Per Share---0.006-0.0060%-0.006+8%-0.001-90%-0.001-75%
Usd Book Value---832870.710-832870.7100%-460558.854-45%-510454.155-39%-474513.046-43%
Usd Book Value Change Per Share---0.004-0.0040%-0.004+8%0.000-90%-0.001-75%
Usd Book Value Per Share---0.009-0.0090%-0.005-45%-0.006-39%-0.005-43%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.015-0.0150%-0.012-21%-0.010-33%-0.011-28%
Usd Free Cash Flow---666337.140-666337.1400%-915136.961+37%-488430.804-27%-509103.494-24%
Usd Free Cash Flow Per Share---0.007-0.0070%-0.010+37%-0.005-27%-0.006-24%
Usd Free Cash Flow To Equity Per Share---0.002-0.0020%-0.004+59%0.001-498%0.000-947%
Usd Market Cap14486351.418+5%13827880.89913827880.8990%15144821.937-9%14552198.470-5%13242573.771+4%
Usd Price Per Share0.159+5%0.1520.1520%0.167-9%0.160-5%0.146+4%
Usd Profit---1334695.635-1334695.6350%-1053352.724-21%-891311.343-33%-955668.872-28%
Usd Revenue--111203.505111203.5050%31829.459+249%66756.299+67%38182.438+191%
Usd Total Gains Per Share---0.004-0.0040%-0.004+8%0.000-90%-0.001-75%
 EOD+6 -2MRQTTM+0 -0YOY+15 -155Y+4 -2610Y+9 -22

3.2. Fundamental Score

Let's check the fundamental score of BioMark Diagnostics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-10.854
Price to Book Ratio (EOD)Between0-1-17.393
Net Profit Margin (MRQ)Greater than0-12.002
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.064
Current Ratio (MRQ)Greater than10.076
Debt to Asset Ratio (MRQ)Less than12.570
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-2.516
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of BioMark Diagnostics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.220
Total0/1 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-03-31. Currency in CAD. All numbers in thousands.

Summary
Total Assets732
Total Liabilities1,882
Total Stockholder Equity-1,150
 As reported
Total Liabilities 1,882
Total Stockholder Equity+ -1,150
Total Assets = 732

Assets

Total Assets732
Total Current Assets126
Long-term Assets606
Total Current Assets
Cash And Cash Equivalents 72
Net Receivables 34
Total Current Assets  (as reported)126
Total Current Assets  (calculated)106
+/- 20
Long-term Assets
Property Plant Equipment 589
Long Term Investments 3
Other Assets 14
Long-term Assets  (as reported)606
Long-term Assets  (calculated)606
+/- 0

Liabilities & Shareholders' Equity

Total Current Liabilities1,664
Long-term Liabilities217
Total Stockholder Equity-1,150
Total Current Liabilities
Short-term Debt 229
Short Long Term Debt 325
Accounts payable 220
Total Current Liabilities  (as reported)1,664
Total Current Liabilities  (calculated)775
+/- 890
Long-term Liabilities
Long term Debt Total 217
Long-term Liabilities  (as reported)217
Long-term Liabilities  (calculated)217
+/- 0
Total Stockholder Equity
Common Stock8,239
Retained Earnings -11,620
Capital Surplus 2,232
Total Stockholder Equity (as reported)-1,150
Total Stockholder Equity (calculated)-1,150
+/- 0
Other
Capital Stock8,239
Cash And Equivalents72
Cash and Short Term Investments 72
Common Stock Shares Outstanding 83,286
Liabilities and Stockholders Equity 732
Net Debt 253
Net Invested Capital -824
Net Working Capital -1,538
Property Plant and Equipment Gross 1,159



Balance Sheet

Currency in CAD. All numbers in thousands.

 Trend2023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-31
> Total Assets 
230
34
40
52
35
637
953
1,472
732
7321,47295363735524034230
   > Total Current Assets 
230
34
40
50
33
628
923
499
126
12649992362833504034230
       Cash And Cash Equivalents 
196
14
17
37
20
612
878
383
72
7238387861220371714196
       Net Receivables 
31
12
22
13
13
16
27
82
34
348227161313221231
   > Long-term Assets 
0
0
0
2
2
9
30
973
606
60697330922000
       Property Plant Equipment 
0
0
0
2
2
9
27
969
589
58996927922000
       Long Term Investments 
0
0
0
0
0
0
3
3
3
333000000
       Other Assets 
0
0
0
0
0
0
0
0
14
1400000000
> Total Liabilities 
82
588
1,105
952
1,254
1,076
1,032
2,107
1,882
1,8822,1071,0321,0761,2549521,10558882
   > Total Current Liabilities 
82
588
1,105
952
1,254
1,076
922
1,501
1,664
1,6641,5019221,0761,2549521,10558882
       Short-term Debt 
0
0
0
0
0
0
0
144
229
2291440000000
       Short Long Term Debt 
0
0
0
0
0
0
0
144
325
3251440000000
       Accounts payable 
47
174
368
160
164
112
27
128
220
2201282711216416036817447
       Other Current Liabilities 
35
414
736
792
1,090
145
108
12
0
0121081451,09079273641435
   > Long-term Liabilities 
0
0
0
0
0
0
110
606
217
217606110000000
       Long term Debt Total 
0
0
0
0
0
0
110
606
217
217606110000000
> Total Stockholder Equity
148
-554
-1,065
-900
-1,219
-439
-79
-636
-1,150
-1,150-636-79-439-1,219-900-1,065-554148
   Common Stock
2,420
3,134
3,249
4,087
4,198
5,433
6,876
7,121
8,239
8,2397,1216,8765,4334,1984,0873,2493,1342,420
   Retained Earnings -11,620-10,118-8,591-7,496-6,281-5,736-5,009-4,293-2,890
   Capital Surplus 
518
605
648
698
811
1,769
1,632
1,698
2,232
2,2321,6981,6321,769811698648605518
   Treasury Stock000000000
   Other Stockholders Equity 
100
0
47
50
53
-145
3
662
0
06623-1455350470100



Balance Sheet

Currency in CAD. All numbers in thousands.




Cash Flow

Currency in CAD. All numbers in thousands.




Income Statement

Currency in CAD. All numbers in thousands.


Latest Income Statement (annual, 2023-03-31)

Gross Profit (+$)
totalRevenue153
Cost of Revenue-0
Gross Profit0153
 
Operating Income (+$)
Gross Profit0
Operating Expense-1,886
Operating Income-1,732-1,886
 
Operating Expense (+$)
Research Development546
Selling General Administrative1,154
Selling And Marketing Expenses0
Operating Expense1,8861,700
 
Net Interest Income (+$)
Interest Income110
Interest Expense-110
Other Finance Cost-110
Net Interest Income-110
 
Pretax Income (+$)
Operating Income-1,732
Net Interest Income-110
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-1,842-1,732
EBIT - interestExpense = -110
-1,842
-1,732
Interest Expense110
Earnings Before Interest and Taxes (EBIT)0-1,732
Earnings Before Interest and Taxes (EBITDA)-1,346
 
After tax Income (+$)
Income Before Tax-1,842
Tax Provision-0
Net Income From Continuing Ops-1,842-1,842
Net Income-1,842
Net Income Applicable To Common Shares-1,842
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0110
 

Technical Analysis of BioMark Diagnostics Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of BioMark Diagnostics Inc. The general trend of BioMark Diagnostics Inc is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine BioMark Diagnostics Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of BioMark Diagnostics Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.24 < 0.25 < 0.285.

The bearish price targets are: 0.205 > 0.2 > 0.2.

Tweet this
BioMark Diagnostics Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging¬†trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of BioMark Diagnostics Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

BioMark Diagnostics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a¬†lagging momentum¬†indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of BioMark Diagnostics Inc.

BioMark Diagnostics Inc Daily Moving Average Convergence/Divergence (MACD) ChartBioMark Diagnostics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of BioMark Diagnostics Inc. The current adx is .

BioMark Diagnostics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows¬†the current trend.
  • Shows¬†potential entry signals.
  • Shows¬†¬†potential exit signals.
  • Can be used to place¬†trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of BioMark Diagnostics Inc.

BioMark Diagnostics Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum¬†indicator, meaning the signals are instant.
  • Ranges¬†between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of BioMark Diagnostics Inc.

BioMark Diagnostics Inc Daily Relative Strength Index (RSI) ChartBioMark Diagnostics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading¬†momentum¬†indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges¬†between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of BioMark Diagnostics Inc.

BioMark Diagnostics Inc Daily Stochastic Oscillator ChartBioMark Diagnostics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,¬†the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of BioMark Diagnostics Inc.

BioMark Diagnostics Inc Daily Commodity Channel Index (CCI) ChartBioMark Diagnostics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of BioMark Diagnostics Inc.

BioMark Diagnostics Inc Daily Chande Momentum Oscillator (CMO) ChartBioMark Diagnostics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and¬†-100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of BioMark Diagnostics Inc.

BioMark Diagnostics Inc Daily Williams %R ChartBioMark Diagnostics Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold¬†

Score

Let's take a look at the Bollinger Bands of BioMark Diagnostics Inc.

BioMark Diagnostics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of BioMark Diagnostics Inc.

BioMark Diagnostics Inc Daily Average True Range (ATR) ChartBioMark Diagnostics Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of BioMark Diagnostics Inc.

BioMark Diagnostics Inc Daily On-Balance Volume (OBV) ChartBioMark Diagnostics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of BioMark Diagnostics Inc.

BioMark Diagnostics Inc Daily Money Flow Index (MFI) ChartBioMark Diagnostics Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for BioMark Diagnostics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-26CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-28CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-16BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-25WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-05-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-05-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-08STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-05-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-05-13RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-05-15STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-05-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-17STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-23BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-27WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-05-28STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-05-29ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-30STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-04MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-06-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-06-10SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-06-11MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-06-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-06-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-06-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-06-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-06-27MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-06-28MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-12STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-16STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

BioMark Diagnostics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of BioMark Diagnostics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.220
Total0/1 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of BioMark Diagnostics Inc with someone you think should read this too:
  • Are you bullish or bearish on BioMark Diagnostics Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about BioMark Diagnostics Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about BioMark Diagnostics Inc

I send you an email if I find something interesting about BioMark Diagnostics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about BioMark Diagnostics Inc.

Receive notifications about BioMark Diagnostics Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.